Think of Enterprise Value as the theoretical takeover price. It is more comprehensive than market capitalization (Market Cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Medicalgorithmics's Enterprise Value is zł294.68 Mil.
Medicalgorithmics's EBIT for the trailing twelve months (TTM) ended in Mar. 2026 was zł-6.47 Mil. Therefore, Medicalgorithmics's EV-to-EBIT ratio for today is -45.56.
EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA. As of today, Medicalgorithmics's Enterprise Value is zł294.68 Mil.
Medicalgorithmics's EBITDA for the trailing twelve months (TTM) ended in Mar. 2026 was zł-1.37 Mil. Therefore, Medicalgorithmics's EV-to-EBITDA ratio for today is -215.56.
EV-to-Revenue is calculated as Enterprise Value divided by its Revenue. As of today, Medicalgorithmics's Enterprise Value is zł294.68 Mil.
Medicalgorithmics's Revenue for the trailing twelve months (TTM) ended in Mar. 2026 was zł34.45 Mil. Therefore, Medicalgorithmics's EV-to-Revenue ratio for today is 8.55.
*** Please note that the current Enterprise Value is calculated using the current market capitalization and the most recently available financial data. If key financial fields—Long-Term Debt & Capital Lease Obligation and Short-Term Debt & Capital Lease Obligation—are recorded as null in the latest reporting period, our data vendor will default to using data from the prior period with valid entries.
Medicalgorithmics (LTS:0QR8) Enterprise Value Explanation
When an investor buy a company, the investor needs to pay not only the common shares, he/she also needs to pay the shareholders of Preferred Stocks. He also assumes the debt of the company, and receives the cash on the company's balance sheet.
If a company has more cash than debt, the investor actually pays less than the Market Cap because he immediately owns the cash once the transaction goes through.
The market value of Preferred Stock needs to be added to the market value of common stocks in the calculation of Enterprise Value.
For the companies with the same Market Cap, the smaller the Enterprise Value is, the cheaper the company is.
Enterprise Value can be negative when the company's net cash is more than its Market Cap. In this case the investor is basically getting the company for free and get paid for that.
1. EV-to-EBIT is calculated as Enterprise Value divided by its EBIT.
Medicalgorithmics's current Enterprise Value is zł294.68 Mil.
Medicalgorithmics's EBIT for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was zł-6.47 Mil.
2. EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA.
Medicalgorithmics's current Enterprise Value is zł294.68 Mil.
Medicalgorithmics's EBITDA for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was zł-1.37 Mil.
Medicalgorithmics's current Enterprise Value is zł294.68 Mil.
Medicalgorithmics's Revenue for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was zł34.45 Mil.
Medicalgorithmics's current Enterprise Value is zł294.68 Mil.
Medicalgorithmics's Cash Flow from Operations for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was zł-0.20 Mil.
Medicalgorithmics's current Enterprise Value is zł294.68 Mil.
Medicalgorithmics's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was zł-14.75 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Medicalgorithmics Enterprise Value Related Terms
Medicalgorithmics Enterprise Value Historical Data
* Premium members only.
The historical data trend for Medicalgorithmics's Enterprise Value can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
LTS:0QR8 vs ABT, SYK, MDT: Enterprise Value Comparison
For the Medical Devices subindustry, Medicalgorithmics's Enterprise Value, along with its competitors' market caps and Enterprise Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Medicalgorithmics Enterprise Value vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Medicalgorithmics's Enterprise Value distribution charts can be found below:
* The bar in red indicates where Medicalgorithmics's Enterprise Value falls into.
Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
Medicalgorithmics's Enterprise Value for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a Enterprise Value of zł294.68 Mil mean?
Medicalgorithmics (LTS:0QR8) has a Enterprise Value of zł294.68 Mil as of Jul. 06, 2026. Enterprise value equals the sum of market cap, debt and preferred shares less cash and equivalents. View historical data on Medicalgorithmics and its competitors.
Is Medicalgorithmics' Enterprise Value too high?
Medicalgorithmics' current Enterprise Value is zł294.68 Mil. Overall, Medicalgorithmics has a GF Score™ of 72/100, reflecting its overall financial health beyond just this single metric.
How does Medicalgorithmics' Enterprise Value compare to ABT and SYK?
Medicalgorithmics' Enterprise Value of zł294.68 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Enterprise Value for a Medical Devices & Instruments company?
A good Enterprise Value depends on the Medical Devices & Instruments industry context. However, Enterprise Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Enterprise Value mean?
A high Enterprise Value can signal that a stock is expensive relative to its fundamentals. Enterprise value equals the sum of market cap, debt and preferred shares less cash and equivalents. View historical data on Medicalgorithmics and its competitors. Medicalgorithmics's current Enterprise Value is zł294.68 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medicalgorithmics stock overvalued right now?
Medicalgorithmics (LTS:0QR8) has a current Enterprise Value of zł294.68 Mil. The stock's GF Value™ is zł31.99, compared to a current price of zł33.07 — trading 3.4% above its estimated fair value. The current Enterprise Value is zł294.68 Mil. Medicalgorithmics' overall GF Score™ is 72/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Enterprise Value calculated?
Enterprise Value is calculated from a company's financial statements. For Medicalgorithmics (LTS:0QR8), the current Enterprise Value is zł294.68 Mil as of Jul. 06, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Medicalgorithmics (LTS:0QR8) Overvalued in 2026?
Based on GuruFocus' analysis, Medicalgorithmics stock appears to be overvalued.
The current stock price of zł33.07 is trading 3.4% above its estimated GF Value™ of zł31.99.
Key valuation signals for LTS:0QR8:
Enterprise Value: zł294.68 Mil
GF Value™: zł31.99 vs. price of zł33.07 (3.4% above fair value)
No single metric tells the full story. See the LTS:0QR8 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Medicalgorithmics SA is a medical technology company. It is engaged in the development of Digital Signal Processing (DSP) algorithms development and software and hardware electronics design for medical applications. The company specializes in providing advance technological solutions in the field of cardiac diagnostics, with a particular focus on ECG signal analysis. The group concentrates on the production and development of its flagship product Pocket ECG - a system for remote monitoring of cardiac arrhythmias. The offered solutions include algorithms and diagnostic systems used in remote heart monitoring. The company operates in Poland, the USA, and other, with majority of revenue from the USA.
72GF Score
Get the complete analysis for LTS:0QR8
Enterprise Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
LTS:0QR8 has been successfully added to your 
